British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
Adherium, a New Zealand-based maker of connected respiratory medical devices, has received the US Food and Drug Administration's 510(k) clearance for connecting its digital monitoring platform with GlaxoSmithKline’s range of Ellipta dry powder inhalers.
The ASX-listed firm offers the Hailie sensor which attaches to an inhaler to remotely monitor and capture medication usage parameters and...
AI-enabled pathology company PathAI has entered into a multiyear drug discovery partnership with pharma giant GlaxoSmithKline.
The agreement will focus on advancing clinical trials and drug development in oncology and for nonalcoholic steatohepatitis (NASH), an aggressive type of fatty liver disease that can lead to serious scarring and liver failure.
"Our partnership will combine GSK and PathAI...
Qure.ai scored FDA 510(k) clearance for its artificial intelligence algorithm that assists providers in placing breathing tubes.
The clearance, which officially came down in late December, is the company's third 510(k). The two previous FDA green lights were regarding its brain CT scan product.
Using chest x-rays, the qXR-BT algorithm can analyze the position of the breathing tube. It automates...
Viome Life Sciences, maker of at-home tests for gut and immune system health, is expanding its partnership with global pharma company GlaxoSmithKline to research and potentially develop interventions for some cancers and autoimmune diseases.
The collaboration will allow the companies to study the connection between the gut microbiome and some chronic diseases, like autoimmune disorders. Viome...
King's College London and global pharmaceutical company, GlaxoSmithKline (GSK), have formed a new five-year partnership to use AI to provide insight into why and how some patients respond to certain cancer treatments.
WHY IT MATTERS
The collaboration will use AI systems to build tools that will support clinical decision-making to help improve patient outcomes.
This move has resulted in the...
US tech giant NVIDIA has announced plans to build the UK’s most powerful supercomputer, to help healthcare researchers.
The Cambridge-1 supercomputer is expected to come online by the end of the year and is intended for artificial intelligence (AI) research into medical challenges, including those presented by COVID-19.
Speaking at his GPU Technology Conference keynote, NVIDIA founder and CEO,...
Earnings reports shared by neurostimulation and digital medicine company NeuroMetrix during a Q2 investors’ call showed a slight drop in total revenue as the company is preparing to place its marketing weight behind the launch of its updated wearable pain relief product, Quell. However, the company remained profitable during the quarter thanks to sales of its other product, DPNCheck.
Dr. Shai N....
GlaxoSmithKline has made a hire signaling its commitment to digital health. Karenann Terrell, former Chief Information Officer at Walmart, will start at GSK in the newly created role of Chief Digital and Technology Officer.
“The impact of technology on the healthcare industry is accelerating and requires us to rethink our approach,” CEO Emma Walmsley said in a statement. “As a member of the...
Madison, Wisconsin-based Propeller Health, maker of several smart inhaler sensors and companion apps, has received FDA 510(k) clearance for its latest offering – a sensor that works with GlaxoSmithKline’s Ellipta inhaler.
This marks the company’s eighth FDA clearance, and was born out of a partnership the company struck up with GSK last December. Given Propeller's growing familiarity with the...
